Stocks

The table gives an overview of all stocks, alphabetically sorted.
 H&D Wireless Sweden Holding B HDWB Apr 9, 2021 0.49 -3.85   
 H&M B HMB Apr 9, 2021 200.05 +0.39   
 Hafnia Limited HAFNIO Apr 9, 2021 17.74 0.00   
 Haldex HLDX Apr 9, 2021 47.55 +0.53   
 Halmslätten HALMEN Apr 9, 2021 106.00 0.00   
 Hamlet Pharma B HAMLETB Apr 9, 2021 7.55 -0.66   
 Handelsbanken A SHBA Apr 9, 2021 96.46 +0.42   
 Handelsbanken B SHBB Apr 9, 2021 106.90 +0.28   
 Hansa Biopharma HNSA Apr 9, 2021 159.50 -1.36   
 HANZA Holding HANZA Apr 9, 2021 17.75 -1.11   
 Havila Shipping HAVIO Apr 9, 2021 2.68 +3.08   
 Havsfrun Investment HAVS Apr 9, 2021 36.50 +6.10   
 Havsfrun Investment B HAVB Apr 9, 2021 36.50 +6.10   
 Havyard Group HYARDO Apr 9, 2021 14.50 0.00   
 Heba B HEBAB Apr 9, 2021 114.00 +0.71   
 Hedera Group HEGR Apr 9, 2021 6.30 +4.13   
 Heimstaden Pref HEIMPREF Apr 9, 2021 350.00 -0.85   
 Heliospectra HELIO Apr 9, 2021 4.76 -3.64   
 Hemcheck Sweden HEMC Apr 9, 2021 3.25 -1.52   
 Herantis Pharma HRNTS Apr 9, 2021 27.40 -2.14   
 Hexagon B HEXAB Apr 9, 2021 841.00 +0.69   
 Hexagon Composites HEXO Apr 9, 2021 48.12 +6.46   
 Hexatronic Group HTRO Apr 9, 2021 122.20 0.00   
 Hexpol B HPOLB Apr 9, 2021 103.15 +0.44   
 Hifab B HIFAB Apr 9, 2021 2.92 -3.95   
 HMS Networks HMS Apr 9, 2021 303.50 +5.38   
 Hofseth BioCare HBCO Apr 9, 2021 8.86 0.00   
 Hoist Finance HOFI Apr 9, 2021 33.88 -0.70   
 Holmen A HOLMA Apr 9, 2021 413.50 +1.35   
 Holmen B HOLMB Apr 9, 2021 398.00 +0.84   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK